Global 4D Bioprinting Market Major Players 2024, Forecast To 2033

17 Apr, 2024

The 4D bioprinting market has seen exponential growth in recent years, starting at $0.07 billion in 2023 and rising to $0.09 billion in 2024, showcasing a remarkable CAGR of 30.3%. This growth in the historic period can be attributed to factors such as the rise in the geriatric population, increasing healthcare expenditure, a surge in 3D bioprinting startups, growing investments in R&D, and the increasing prevalence of chronic diseases. Looking ahead to 2028, the market is poised for continued exponential growth, projected to reach $0.26 billion with a CAGR of 29.9%. This growth is expected to be driven by factors including increasing demand for organ transplants, a rising aging population, growing prevalence of chronic diseases, increasing healthcare expenditure, and rising demand for personalized medicine. Additionally, major trends in the forecast period encompass technological advancements, collaborations between academia and industry, integration of artificial intelligence, a shift towards decentralized manufacturing, and integration with 3D imaging technologies.

Global 4D Bioprinting Market Key Driver

The growth trajectory of the 4D bioprinting market is anticipated to be propelled by the escalating demand for organ transplants. Organ transplants entail surgically transferring organs or tissues from donors to recipients grappling with organ failure or dysfunction, aiming to save lives and improve quality of life. 4D bioprinting emerges as a key player in advancing regenerative medicine by fabricating complex tissues and organs with functional capabilities, offering a promising solution to the shortage of donor organs and enhancing transplant outcomes. Notably, in January 2022, the number of organ transplantations in the United States witnessed a 5.90% increase from the previous year, reaching 41,354, as per data from the Organ Procurement and Transplantation Network (OPTN). Hence, the mounting demand for organ transplants is a driving force behind the growth of the 4D bioprinting market, which attained a market size of $C billion in 2023 and is projected to reach $D billion by 2028. The expansion of the 4D bioprinting market is poised to be fueled by the rising demand for personalized medicine. Personalized medicine tailors healthcare decisions and treatments to individual patient characteristics, and 4D bioprinting plays a pivotal role by fabricating smart biological structures adaptable to environmental changes. In 2022, the approval of 12 new personalized medicines accounted for about 34% of all newly approved therapies, signaling a significant uptick in personalized medicine adoption. This trend underscores the indispensable role of 4D bioprinting in catering to the demands of personalized medicine, driving the market's growth. Thus, the rising demand for personalized medicine is set to propel the 4D bioprinting market, which recorded a market size of $E billion in 2023 and is forecasted to reach $F billion by 2028.

Get A Free Sample Of The Global 4D Bioprinting Market Report

Global 4D Bioprinting Market Segments

The 4D bioprinting market covered in this report is segmented –
1) By Type Of Technology: Extrusion-Based Technology, Laser-Based Technology, Inkjet-Based Technology, Other Types
2) By Application Area: Biomedical Application, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research And Development, Other End-Users
By Geography:The regions covered in the 4D bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. North America was the largest region in the 4D bioprinting market in 2023. The regions covered in the 4D bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Major 4D Bioprinting Market Industry Players

3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.

Get The Full Global 4D Bioprinting Market Report

4D Bioprinting Market Overview

4D bioprinting is an advanced manufacturing technology that integrates 3D bioprinting with dynamic functionalities, enabling the fabrication of biomimetic structures capable of changing shape or function over time in response to external stimuli. 4D bioprinting allows for the creation of tissues and structures that can mimic the dynamic functionalities of natural tissues

4D Bioprinting Global Market Report 2023 provides data on the global 4d bioprinting market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The 4d bioprinting market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.